Harnessing AI to Revolutionize Drug Discovery
AWS Executive Insights · Amazon Web Services
Audio is streamed directly from the publisher (rss.art19.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Tanuja Randery of AWS sits down with Dave Hallett, Chief Science Officer and Interim CEO of Exscientia, to discuss how the company is leveraging AI and cloud technology to transform the drug discovery process. Hallett explains Exscientia's approach to improving efficiency and patient success rates, and explores the importance of partnerships and building diverse, high-performing teams in the rapidly evolving landscape of scientific innovation.
Resources:
Amazon Bedrock: https://aws.amazon.com/bedrock/
Amazon Q: https://aws.amazon.com/q/
AWS Generative AI Innovation Center: https://aws.amazon.com/generative-ai/innovation-center/